Chronic Kidney Disease (CKD) affects about 37 million adults in the United States. This is around 15% of adults. Many people with CKD eventually reach End-Stage Renal Disease (ESRD). At this stage, they need dialysis or a kidney transplant. Treating CKD and ESRD is hard for healthcare systems, doctors, and patients. Recently, there has been a move toward value-based payment models in kidney care. These models aim to improve patient health while controlling rising healthcare costs.
Medical practice administrators, owners, and IT managers in nephrology need to understand how value-based payment models change care and use new technology. This helps them adjust how they run their practices and support healthcare workers.
Value-based payment models reward healthcare providers for the quality and efficiency of care, not for how many services they provide. This is different from the traditional fee-for-service (FFS) system, which pays providers based on the number of procedures or visits, no matter the results for the patient.
The Centers for Medicare & Medicaid Services (CMS) started several value-based programs for kidney care. Early efforts mostly focused on ESRD and dialysis care. Programs like the ESRD Prospective Payment System and the ESRD Quality Incentive Program (QIP) were created. The ESRD QIP began in 2012 and holds dialysis centers responsible for quality. Poor performance on 14 clinical measures can lead to financial penalties of up to 2%. Studies show that centers with lower QIP scores have higher death rates among dialysis patients, showing the link between quality and outcomes.
More recent programs under the Advancing American Kidney Health initiative cover more people with CKD. Two main programs are:
These changes aim for earlier treatment, prevention, and coordinated care to reduce hospital stays and costs over time.
Using value-based payment models means nephrology practices have to change how they work. Eight independent nephrology practices in the St. Louis area teamed up with Strive Health and SSM Health to try value-based contracts. This group has 38 nephrologists who care for over 1,300 patients with chronic or end-stage kidney disease.
Dr. Gary Singer from Midwest Nephrology Associates said the fee-for-service system is not sustainable. He pointed out the need for full care with help from technology and operations. With value-based models, nephrologists don’t only treat problems after they happen. They manage patient health early using teams and data that predicts risks.
Value-based care asks nephrology practices to focus on:
These teams share tasks that nephrologists used to do alone. This helps with patient education, following medication plans, and nutrition support.
Data from big healthcare providers like Fresenius Medical Care show the benefits of value-based kidney care. Fresenius Health Partners said hospital stays for ESRD patients dropped by over 34% in five years because of care coordination and using data for predictions.
Unlike fee-for-service models that lost about 32% of medical income during the COVID-19 pandemic due to fewer visits, value-based models stayed more stable. This happens because value-based care focuses on results, not just the number of visits. Providers can put patient health first instead of trying to do many services.
Value-based contracts make providers lower unnecessary hospital and emergency visits. Money saved can be used for better care tools and patient support, which helps keep improving care.
Accountable Care Organizations (ACOs) are important for value-based kidney care. ACOs are groups of doctors, hospitals, and other health workers who manage care together for specific patients. They share financial responsibility.
In kidney care, ACOs improve person-centered care by working together. They use Certified Electronic Health Records (EHR) to share patient information. ACOs provide telehealth, home visits, pharmacy help, and social services to meet patient needs.
Research shows ACOs reduce unnecessary hospital stays and emergency visits by improving care continuity. CMS gave an example of John, a 69-year-old man with many health problems. He had fewer emergency trips and better care because of ACO support like home nurse visits and good communication.
ACOs also focus on social issues like safe housing and good nutrition that affect health. These efforts help reduce health gaps in patients with long-term diseases like CKD.
New technology like Artificial Intelligence (AI) and workflow automation is becoming important in value-based kidney care. Strive Health gives nephrologists access to a machine learning platform. It looks at data from many sources to give a full picture of a patient’s health.
AI helps doctors by:
Automating tasks such as making appointments, sending reminders, and answering calls lowers the workload. This lets staff focus more on patient care. AI tools like Simbo AI also help handle many patient calls quickly. This makes patients happier by cutting wait times and answering urgent questions fast.
For IT managers, adding AI means smoother work and lower costs. These tools can connect with current EHRs and management systems to update data in real time and help teams work better.
AI also helps manage population health by finding at-risk patients and enabling targeted outreach. This fits well with value-based care because it focuses on catching problems early instead of waiting until illness is severe.
Despite benefits, moving to value-based kidney care has challenges. Adjusting for risks is hard because many kidney patients have other diseases that affect results and costs. Combining data from different places—hospitals, clinics, home care—needs strong IT systems.
Providers may struggle to meet quality goals if they do not have enough support or resources for coordinating care. Quality measurement is changing to include both clinical data and patient experiences. For example, CMS looks at things like how soon treatment starts, patient satisfaction, and following guidelines for CKD and ESRD.
Keeping care strong over time needs thought. Reducing hospital visits is good, but providers also need ongoing help and fair pay to keep doing quality work.
Value-based payment models change how nephrology groups work. More payors, both government and private, are using these models. Practices must get ready for new financial rules and care duties.
Success depends on:
Practice administrators and owners should invest in new technology and train staff. IT managers need to make sure AI tools connect safely with existing systems and that patient data flows well between caregivers.
The changing payment system shows how important it is to give coordinated, patient-focused kidney care that improves quality and controls costs. Partnerships like those in St. Louis with independent nephrology groups, Strive Health, and SSM Health show that value-based models using advanced data can make kidney care more sustainable and effective.
This move to value-based care in kidney disease is still new. But it may improve outcomes, reduce health differences, and lower the heavy costs of CKD nationwide. Practices that adjust early and invest in AI and automation will be better ready for the challenges and chances this care model brings.
The partnership aims to deliver higher-quality, cost-effective kidney care to Medicare beneficiaries in the greater St. Louis area by adopting a value-based contracting model.
The partnership includes eight nephrology practices representing 38 nephrologists and over 1,300 patients with chronic kidney disease or end-stage kidney disease.
The conventional fee-for-service model is deemed unsustainable, and a comprehensive approach is needed to improve outcomes and reduce costs in kidney care.
They provide technological, operational, and administrative support, including access to a machine learning platform for analyzing patient data and improving care management.
These teams support nephrologists by managing comorbidities and providing comprehensive care, enhancing the overall nephrology care experience for patients.
The platform analyzes data from various sources to give a holistic view of each patient’s journey, helping nephrologists manage risks related to hospitalization and disease progression.
The CDC estimates that kidney disease affects 37 million adults, which is about 15% of the U.S. adult population.
End-stage kidney disease accounts for over 7% of Medicare spending, despite only 1% of Medicare beneficiaries having this condition.
These payment models focus on preventing disease progression and promoting early detection, aiming to transform the healthcare system for kidney care.
Strive Health partners with commercial and Medicare Advantage payors, Medicare, health systems, and nephrologists to create flexible value-based payment arrangements.
Simbo is using AI agents to automate all phone related workflows. Connect now to know more.
Schedule AI Agents Demo Now© Since 2019, Simbo AI.
